Integer Holdings Corporation
ITGR Healthcare Medical Devices
Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
- Revenue
- −3.86%
- EPS
- −61.0%
- Free cash flow
- −65.2%
- Total debt
- +4.06%
Quarter to September 2026, against a year earlier
Follow ITGR
Alert me
Integer Holdings Corporation (ITGR) P/S ratio
As of 6 November 2026, Integer Holdings Corporation (ITGR) trades at a P/S ratio of 2.4×. Over the past ten years it has ranged from 0.4× (October 2016) to 3.1× (April 2021); the current reading is higher than 81% of that period. That is below the Medical Devices industry median of 2.5× and below the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 1.5× | (43.34%) |
| FY2024 | 2.6× | 23.28% |
| FY2023 | 2.1× | 23.50% |
| FY2022 | 1.7× | (26.33%) |
| FY2021 | 2.3× | (6.91%) |
| FY2020 | 2.5× | 19.10% |
| FY2019 | 2.1× | 3.41% |
| FY2018 | 2.0× | 60.73% |
| FY2017 | 1.3× | 48.40% |
| FY2016 | 0.8× | (46.36%) |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 2.4× | 36.61% |
| Jun 2026 | 1.7× | 6.07% |
| Mar 2026 | 1.6× | 10.59% |
| Dec 2025 | 1.5× | (25.76%) |
| 43 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| ITGR Integer Holdings Corporation | 2.4× |
| NEOG Neogen Corporation compare | 2.9× |
| TMDX TransMedics Group, Inc. compare | 3.3× |
| LIVN LivaNova PLC compare | 3.4× |
| UFPT UFP Technologies, Inc. compare | 3.6× |
| HAE Haemonetics Corporation compare | 4.1× |
| IRTC iRhythm Holdings, Inc. compare | 5.1× |
| AXGN AxoGen, Inc. compare | 10.1× |
| TXG 10x Genomics compare | 12.4× |
| Medical Devices industry median | 2.5× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on ITGR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement